COMMUNIQUÉS West-GlobeNewswire

VBL Therapeutics Awarded $2.5 Million Non-Dilutive Grant by the Israel Innovation Authority
09/04/2018
TEL AVIV, Israel, April 09, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ) today announced that it has been awarded a grant of 8.9 million New Israeli Shekels (approximately $2.5 million) by the Israel [...]
TRACON Pharmaceuticals Announces Closing of Previously Announced Private Placement and Appointment of Ted Wang, Ph.D., of Puissance Capital Management, to Board of Directors
09/04/2018
SAN DIEGO, April 09, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
Rezolute Announces Appointment of Congenital Hyperinsulinism Therapeutic Area Expert, Dr. Christine Ferrara, as Director of Clinical Development
09/04/2018
LOUISVILLE, Colo., April 09, 2018 (GLOBE NEWSWIRE) -- Rezolute , Inc. (“Rezolute” or the “Company”) (OTCQB:RZLT), a clinical stage biopharmaceutical company specializing in the development of innovative drug therapies [...]
MediWound’s NexoBrid® to be Highlighted in Presentations at the American Burn Association 50th Annual Meeting Being Held on April 10-13, 2018 in Chicago
09/04/2018
Presentations highlight European consensus around the efficacy and benefits of NexoBrid use in severe burns YAVNE, Israel, April 09, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated [...]
Aeterna Zentaris Files Management Information Circular
09/04/2018
CHARLESTON, S.C., April 09, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) is pleased to announce that it has filed its Management Information Circular for the upcoming Annual and Special [...]
Immunomedics Appoints Dr. Robert Iannone Head of Research & Development and Chief Medical Officer
09/04/2018
MORRIS PLAINS, N.J., April 09, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”), a leader in the field of antibody-drug conjugates (ADCs), today announced the appointment [...]
Novo Nordisk A/S - Share repurchase programme
09/04/2018
Bagsværd, Denmark, 9 April 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Share buy-back week 14/2018
09/04/2018
Announcement 9 April 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]
Conatus Pharmaceuticals Announces Upcoming Oral Presentation at EASL Annual Meeting
09/04/2018
Pan-caspase Inhibitor IDN-7314 Reduces Inflammation and Liver Injury in Mouse Model of PSC SAN DIEGO, April 09, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ: CNAT ), a biotechnology company focused on [...]
Kura Oncology Announces Upcoming Presentations at AACR Annual Meeting 2018
09/04/2018
SAN DIEGO, April 09, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that three [...]
The Joint Corp. Acquires Clinic in San Diego
09/04/2018
– Initiates Growth Acceleration Plan with Clinic Buyback – – Expands Regional Cluster and Leverages Existing Infrastructure – SCOTTSDALE, Ariz., April 09, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT ), a [...]
Cannabis Wheaton Announces Acquisition of Robinson's Cannabis
09/04/2018
VANCOUVER, British Columbia, April 09, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (the " Company ") announces that it has entered into a share purchase agreement (the " Share Purchase Agreement [...]
Rhizen Pharmaceuticals S.A. receives FDA orphan-drug designation for Tenalisib (RP6530) for treatment of cutaneous T-cell lymphoma (CTCL)
09/04/2018
La Chaux-de-Fonds, Switzerland, April 09, 2018 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A., today announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for the active moiety [...]
MPX Adds a Fourth Dispensary in Phoenix and Triples Capacity for MPX Concentrate Production in Arizona
09/04/2018
TORONTO, April 09, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that the official opening of the its newest “Health for Life” medical [...]
Clinical Laserthermia Systems Introduces MRI-Guided Laser Ablation System for Minimally-Invasive Treatment of Soft Tissue
09/04/2018
FRAMINGHAM, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc . (CLS) a subsidiary of CLS AB in Lund, Sweden, today announced the availability of its TRANBERG® Thermal Therapy System [...]
G1 Therapeutics to Present Preclinical Data on CDK4/6 Inhibitors Trilaciclib and G1T38 at the 2018 American Association for Cancer Research (AACR) Annual Meeting
09/04/2018
RESEARCH TRIANGLE PARK, N.C., April 09, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that preclinical data on both of the company’s CDK4/6 inhibitors [...]
RedHill Biopharma Provides Semi-Annual Business Update
09/04/2018
TEL-AVIV, Israel and RALEIGH, N.C., April 09, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Tyme Provides Clinical and Corporate Update for Fiscal Year End 2018
09/04/2018
NEW YORK, April 09, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced a clinical and corporate update [...]
BioVie Inc. (OTCQB:BIVI) Attains Milestone
09/04/2018
Company Reaches 50% Patient Enrollment in Phase 2a Clinical Trial of BIV201 for Refractory Ascites BEVERLY, Mass., April 09, 2018 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB:BIVI), a clinical-stage company focused on the [...]

Pages